Exploring the Experiences of Women and Health Care Workers in the Context of PMTCT Option B Plus in Malawi

Fabian Cataldo(Dignitas International), Sam Phiri(Lighthouse Trust), Mina C. Hosseinipour, Florence Kasende(Dignitas International), Misheck J. Nkhata(Dignitas International), Frank Chimbwandira(Centers for Disease Control and Prevention), Erik J Schouten(Public Health Institute of Malawi), Levison Chiwaula(University of Malawi), Monique van Lettow(University of Toronto), Hannock Tweya(International Union Against Tuberculosis and Lung Disease), Atupele Kapito–Tembo(University of Malawi), Nora E. Rosenberg, Veena Sampathkumar(Christian Health Association of Malawi), Michael Eliya(Ministry of Health)
JAIDS Journal of Acquired Immune Deficiency Syndromes
December 31, 2016
10.1097/qai.0000000000001273
Cited by 66

Related Papers

Retention in care under universal antiretroviral therapy for HIV-infected pregnant and breastfeeding women (‘Option B+’) in Malawi
|AIDS|2014|375
Prevention of mother-to-child transmission of HIV and the health-related Millennium Development Goals: time for a public health approach
|The Lancet|2011|237
Retention in care during the first 3 years of antiretroviral therapy for women in Malawi's option B+ programme: an observational cohort study
|The Lancet HIV|2016|177
Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial
|PLoS Medicine|2018|171
Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial
|The Lancet HIV|2020|171